# IMMUNE PHARMACEUTICALS INC

IMMUNE PHARMACEUTICALS INC is a company headquartered in Fort Lee, NJ, United States.

## Company overview

- **Legal name:** IMMUNE PHARMACEUTICALS INC
- **Former names in filing history:** EPICEPT CORP (2002-11-20 to 2013-08-16)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Fort Lee, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001208261

## About

IMMUNE PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001208261, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-04-02, it reported annual revenue of USD 0; net income of USD -17,889,000; total assets of USD 28,608,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$17.9M (USD -17,889,000)
- **Total assets:** $28.6M (USD 28,608,000)
- **Cash and equivalents:** $6.8M (USD 6,776,000)
- **Operating cash flow:** -$11.6M (USD -11,559,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$32.7M (USD -32,661,000)
- **Total assets:** $19.1M (USD 19,105,000)
- **Cash and equivalents:** $271,000 (USD 271,000)
- **Operating cash flow:** -$12.3M (USD -12,307,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$17.2M (USD -17,157,000)
- **Total assets:** $36.2M (USD 36,184,000)
- **Cash and equivalents:** $4.5M (USD 4,543,000)
- **Operating cash flow:** -$13.9M (USD -13,906,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $2,000 (USD 2,000)
- **Net income:** -$23.6M (USD -23,550,000)
- **Total assets:** $37.9M (USD 37,864,000)
- **Cash and equivalents:** $6.8M (USD 6,767,000)
- **Operating cash flow:** -$13.9M (USD -13,864,000)

## Recent SEC filings

- Form 8-K — filed 2021-04-13 — period 2021-04-13
- Form 8-K — filed 2021-04-12 — period 2021-04-12
- Form SC 13G — filed 2019-08-09 — FORM13G
- Form 8-K — filed 2019-03-08 — period 2019-02-17 — FORM 8-K
- Form 8-K — filed 2019-02-14 — period 2019-02-08 — FORM 8-K
- Form 424B4 — filed 2019-02-07 — 424B4
- Form 8-K — filed 2018-12-19 — period 2018-12-19 — FORM 8-K
- Form 8-K — filed 2018-12-06 — period 2018-12-05 — FORM 8-K
- Form 8-K — filed 2018-11-28 — period 2018-11-23 — 8-K
- Form 8-K — filed 2018-11-26 — period 2018-11-26 — FORM 8-K
- Form S-1 — filed 2018-11-21 — FORM S-1
- Form 10-Q — filed 2018-11-14 — period 2018-09-30 — FORM 10-Q

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/immune-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology